Inozyme Pharma, Inc.
INZYDelisted Jul 1, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001693011
Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.
Holders of 5% or more of INZY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Inozyme Pharma, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 13G | 6.59%4.25M shares | New | Jun 4, 20251 filing | Jun 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Inozyme Pharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 27, 20255:42 PM ET | Pivotal bioVenture Partners Fund I, L.P.and 9 others | 13D/A | 0.00%0 shares | –Below 5% | Jul 1, 2025 | SEC |
| Aug 14, 202512:38 PM ET | Beryl Capital Management LLCand 3 others | 13G/A | 0.00%0 shares | −9.80 ppfrom 9.80%Below 5% | Jun 30, 2025 | SEC |
| Aug 13, 20254:31 PM ET | Rock Springs Capital Management LPand 4 others | 13G/A | 0.00%0 shares | –Below 5% | Jun 30, 2025 | SEC |
| Aug 12, 20259:02 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 0.00%0 shares | –Below 5% | Jun 30, 2025 | SEC |
| Jul 17, 20257:54 PM ET | BlackRock, Inc. | 13G/A | 4.10%2.66M shares | –Below 5% | Jun 30, 2025 | SEC |
| Jun 4, 20255:09 PM ET | Glazer Capital, LLCand 1 other | 13G | 6.59%4.25M shares | New | May 28, 2025 | SEC |
| May 30, 20255:24 PM ET | Affinity Asset Advisors, LLCand 1 other | 13G/A | 2.89%1.87M shares | –Below 5% | May 20, 2025 | SEC |
| May 23, 20254:22 PM ET | Beryl Capital Management LLCand 3 others | 13G | 9.80%6.32M shares | New | May 16, 2025 | SEC |
| Apr 23, 202510:28 AM ET | Eventide Asset Management, LLCand 2 others | 13G/A | 3.46%2.22M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20251:59 PM ET | Samlyn Capital, LLCand 2 others | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Inozyme Pharma, Inc. shares.
No Form 144 notices for Inozyme Pharma, Inc. are on file.